Back to Search
LORI COLLINS, RPH, PHARM.D
RPH, PHARM.D
Pharmacist
NPI: 1851000251Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Basal cytokeratin and epidermal growth factor receptor expression are not predictive of BRCA1 mutation status in women with triple-negative breast cancers.
PMID 19390427·Am J Surg Pathol·2009
8-other
Comparison of a phased experimental approach and a single randomized clinical trial for developing multicomponent behavioral interventions.
PMID 19254929·Clin Trials·2009
4-observational
TCDD exposure disrupts mammary epithelial cell differentiation and function.
PMID 19490989·Reprod Toxicol·2009
7-preclinical
Potential role of tissue microarrays for the study of biomarker expression in benign breast disease and normal breast tissue.
PMID 19363445·Appl Immunohistochem Mol Morphol·2009
8-other
Comparison of estrogen receptor results from pathology reports with results from central laboratory testing.
PMID 18230800·J Natl Cancer Inst·2008
4-observational
An approach to transcriptome analysis of non-model organisms using short-read sequences.
PMID 19425143·Genome Inform·2008
8-other
2,3,7,8-Tetracholorodibenzo-p-dioxin exposure disrupts granule neuron precursor maturation in the developing mouse cerebellum.
PMID 18227101·Toxicol Sci·2008
7-preclinical
Papillary lesions of the breast: selected diagnostic and management issues.
PMID 18171414·Histopathology·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 949 LINCOLN WAY E
CHAMBERSBURG, PA 17201 - Phone
- (717) 261-1303
Quick Facts
- NPI
- 1851000251
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile